{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T13:37:38Z","timestamp":1776087458075,"version":"3.50.1"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Several endocrine abnormalities were reported in children with Prader\u2013Willi syndrome (PWS), including hypothyroidism. Growth hormone (GH) treatment may impact the thyroid hormone axis by direct inhibition of T4 or TSH secretion or by increased peripheral conversion of free T4 (FT4) to T3.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>The objective of this study is to evaluate thyroid function during GH treatment in a large group of children with PWS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Serum FT4, T3, and TSH are measured in a 2-year randomized controlled GH trial (RCT) and 10-year longitudinal GH study (GH treatment with 1.0 mg\/m\u00b2\/day [\u223c0.035 mg\/kg\/day]).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Forty-nine children with PWS were included in the 2-year RCT (median [interquartile range, IQR] age: GH group 7.44 [5.47-11.80] years, control group 6.04 [4.56-7.39] years). During the first 6 months, median (IQR) FT4 standard deviation score (SDS) decreased in the GH group from \u22120.84 (\u22121.07 to \u22120.62) to \u22121.32 (\u22121.57 to \u22121.08) (P &amp;lt; .001) and T3 SDS increased from 0.31 (\u22120.01-0.63) to 0.56 (0.32-0.79) (P = .08), while in the control group, FT4 and T3 SDS remained unchanged. In our 10-year GH study, 240 children with PWS (median [IQR] age: 1.27 (0.54-4.17) years] were included. Between 2 and 10 years, median (IQR) FT4 SDS remained unchanged, being \u22120.87 (\u22120.98 to \u22120.77) after 2 years and \u22120.88 (\u22121.03 to \u22120.74) after 10 years (P = .13). TSH SDS decreased from \u22120.35 (\u22120.50 to \u22120.21) after 2 years to \u22120.68 (\u22120.84 to \u22120.53) after 10 years (P &amp;lt; .001).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Our findings suggest that GH treatment decreases FT4 levels, due to increased peripheral conversion of FT4 to T3 in the first months of treatment, but thereafter, FT4 and T3 normalize and remain stable during long-term GH treatment in almost all children and adolescents with PWS.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ejendo\/lvae088","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T10:58:06Z","timestamp":1721905086000},"page":"126-133","source":"Crossref","is-referenced-by-count":1,"title":["Thyroid hormone levels in children with Prader\u2013Willi syndrome: a randomized controlled growth hormone trial and 10-year growth hormone study"],"prefix":"10.1093","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6882-0086","authenticated-orcid":false,"given":"Demi J","family":"Trueba-Timmermans","sequence":"first","affiliation":[{"name":"Dutch Reference Center for Prader\u2013Willi Syndrome , 3015 CN Rotterdam , The Netherlands"},{"name":"Dutch Growth Research Foundation , 3016 AH Rotterdam , The Netherlands"},{"name":"Department of Pediatrics, Subdivision of Endocrinology, Erasmus University Medical Center-Sophia Children's Hospital , 3015 CN Rotterdam , The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lionne N","family":"Grootjen","sequence":"additional","affiliation":[{"name":"Dutch Reference Center for Prader\u2013Willi Syndrome , 3015 CN Rotterdam , The Netherlands"},{"name":"Dutch Growth Research Foundation , 3016 AH Rotterdam , The Netherlands"},{"name":"Department of Pediatrics, Subdivision of Endocrinology, Erasmus University Medical Center-Sophia Children's Hospital , 3015 CN Rotterdam , The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerthe F","family":"Kerkhof","sequence":"additional","affiliation":[{"name":"Dutch Reference Center for Prader\u2013Willi Syndrome , 3015 CN Rotterdam , The Netherlands"},{"name":"Department of Pediatrics, Subdivision of Endocrinology, Erasmus University Medical Center-Sophia Children's Hospital , 3015 CN Rotterdam , The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edmond H H M","family":"Rings","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Erasmus University Medical Center-Sophia Children's Hospital , 3015 CN Rotterdam , The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1384-7628","authenticated-orcid":false,"given":"Anita C S","family":"Hokken-Koelega","sequence":"additional","affiliation":[{"name":"Dutch Reference Center for Prader\u2013Willi Syndrome , 3015 CN Rotterdam , The Netherlands"},{"name":"Dutch Growth Research Foundation , 3016 AH Rotterdam , The Netherlands"},{"name":"Department of Pediatrics, Subdivision of Endocrinology, Erasmus University Medical Center-Sophia Children's Hospital , 3015 CN Rotterdam , The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,7,25]]},"reference":[{"issue":"1","key":"2024082910340762900_lvae088-B1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/gim.0b013e31822bead0","article-title":"Prader\u2013Willi syndrome","volume":"14","author":"Cassidy","year":"2012","journal-title":"Genet Med."},{"issue":"11","key":"2024082910340762900_lvae088-B2","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1210\/jc.2008-0649","article-title":"Recommendations for the diagnosis and management of Prader\u2013Willi syndrome","volume":"93","author":"Goldstone","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"S423","key":"2024082910340762900_lvae088-B3","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1651-2227.1997.tb18369.x","article-title":"Prader\u2013Willi syndrome and the hypothalamus","volume":"423","author":"Swaab","year":"1997","journal-title":"Acta Paediatr Suppl"},{"issue":"2","key":"2024082910340762900_lvae088-B4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000313377","article-title":"Endocrine disorders in children with Prader\u2013Willi syndrome\u2013data from 142 children of the French database","volume":"74","author":"Diene","year":"2010","journal-title":"Horm Res Paediatr"},{"issue":"2","key":"2024082910340762900_lvae088-B5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s11154-019-09502-2","article-title":"Willi syndrome: an uptodate on endocrine and metabolic complications","volume":"20","author":"Muscogiuri","year":"2019","journal-title":"Rev Endocr Metab Disord"},{"issue":"3","key":"2024082910340762900_lvae088-B6","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-2265.2007.02910.x","article-title":"Thyroid hormone levels in children with Prader\u2013Willi syndrome before and during growth hormone treatment","volume":"67","author":"Festen","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2024082910340762900_lvae088-B7","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1515\/jpem.2010.076","article-title":"Predictors and growth consequences of central hypothyroidism in pediatric patients receiving recombinant human growth hormone","volume":"23","author":"Wong","year":"2010","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"3","key":"2024082910340762900_lvae088-B8","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jpeds.2013.03.058","article-title":"Thyroid function from birth to adolescence in Prader\u2013Willi syndrome","volume":"163","author":"Sharkia","year":"2013","journal-title":"J Pediatr"},{"issue":"4","key":"2024082910340762900_lvae088-B9","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/ajmg.a.61499","article-title":"Effects of growth hormone treatment on thyroid function in pediatric patients with Prader\u2013Willi syndrome","volume":"182","author":"Oto","year":"2020","journal-title":"Am J Med Genet A"},{"issue":"3","key":"2024082910340762900_lvae088-B10","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1365-2265.2008.03228.x","article-title":"Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader\u2013Willi syndrome","volume":"69","author":"Festen","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"2024082910340762900_lvae088-B11","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1210\/jc.2013-2012","article-title":"Eight years of growth hormone treatment in children with Prader\u2013Willi syndrome: maintaining the positive effects","volume":"98","author":"Bakker","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2024082910340762900_lvae088-B12","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1365-2265.2007.03126.x","article-title":"Mental and motor development before and during growth hormone treatment in infants and toddlers with Prader\u2013Willi syndrome","volume":"68","author":"Festen","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"2024082910340762900_lvae088-B13","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.3390\/jcm11092496","article-title":"Long-Term growth hormone treatment of children with PWS: the earlier the start, the better the outcomes?","volume":"11","author":"Grootjen","year":"2022","journal-title":"J Clin Med"},{"issue":"9","key":"2024082910340762900_lvae088-B14","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00787-014-0662-4","article-title":"Behavior in children with Prader\u2013Willi syndrome before and during growth hormone treatment: a randomized controlled trial and 8-year longitudinal study","volume":"24","author":"Lo","year":"2015","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"11","key":"2024082910340762900_lvae088-B15","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1210\/jc.2009-0454","article-title":"Efficacy and safety of long-term continuous growth hormone treatment in children with Prader\u2013Willi syndrome","volume":"94","author":"De Lind Van Wijngaarden","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2024082910340762900_lvae088-B16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1365-2265.2000.01071.x","article-title":"Changes in serum thyroid hormones levels and their mechanisms during long-term growth hormone (GH) replacement therapy in GH deficient children","volume":"53","author":"Portes","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024082910340762900_lvae088-B17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1651-2227.1997.tb18372.x","article-title":"Effects of growth hormone treatment on growth and body composition in Prader\u2013Willi syndrome: a preliminary report. The Swedish National Growth Hormone Advisory Group","volume":"423","author":"Lindgren","year":"1997","journal-title":"Acta Paediatr Suppl"},{"issue":"1","key":"2024082910340762900_lvae088-B18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1067\/mpd.2000.105369","article-title":"Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader\u2013Willi syndrome","volume":"137","author":"Myers","year":"2000","journal-title":"J Pediatr"},{"issue":"5","key":"2024082910340762900_lvae088-B19","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1507\/endocrj.EJ22-0509","article-title":"Very young children with Prader\u2013Willi syndrome are refractory to growth hormone-associated decreases in free thyroxine levels","volume":"70","author":"Konishi","year":"2023","journal-title":"Endocr J"},{"issue":"20","key":"2024082910340762900_lvae088-B20","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World medical association declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"2","key":"2024082910340762900_lvae088-B21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/adc.82.2.107","article-title":"Body index measurements in 1996-7 compared with 1980","volume":"82","author":"Fredriks","year":"2000","journal-title":"Arch Dis Child"},{"issue":"3","key":"2024082910340762900_lvae088-B22","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1203\/00006450-200003000-00006","article-title":"Continuing positive secular growth change in The Netherlands 1955-1997","volume":"47","author":"Fredriks","year":"2000","journal-title":"Pediatr Res"},{"issue":"9","key":"2024082910340762900_lvae088-B23","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1210\/jc.2012-1759","article-title":"Serum thyroid hormone levels in healthy children from birth to adulthood and in short children born small for gestational age","volume":"97","author":"Lem","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2024082910340762900_lvae088-B24","first-page":"3493","article-title":"Changes in thyroid hormone levels during growth hormone therapy in initially euthyroid patients: lack of need for thyroxine supplementation","volume":"83","author":"Wyatt","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2024082910340762900_lvae088-B25","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1515\/jpem-2020-0151","article-title":"Effect of growth hormone therapy on thyroid function in isolated growth hormone deficient and short small for gestational age children: a two-year study, including on assessment of the usefulness of the thyrotropin-releasing hormone (TRH) stimulation test","volume":"33","author":"Ebuchi","year":"2020","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"12","key":"2024082910340762900_lvae088-B26","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1055\/s-2005-921104","article-title":"Changes of thyroid function during long-term hGH therapy in GHD children. A possible relationship with catch-up growth?","volume":"37","author":"Seminara","year":"2005","journal-title":"Horm Metab Res"},{"issue":"6","key":"2024082910340762900_lvae088-B27","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1159\/000356907","article-title":"Correlation between severity of growth hormone deficiency and thyroid metabolism and effects of long-term growth hormone treatment on thyroid function in children with idiopathic growth hormone deficiency","volume":"81","author":"Ciresi","year":"2014","journal-title":"Horm Res Paediatr"},{"issue":"4","key":"2024082910340762900_lvae088-B28","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/J.1365-2265.2010.03840.X","article-title":"Thyroid axis dysfunction in patients with Prader\u2013Willi syndrome during the first 2 years of life","volume":"73","author":"Vaiani","year":"2010","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvae088\/58646696\/lvae088.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/191\/2\/126\/58814734\/lvae088.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/191\/2\/126\/58814734\/lvae088.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T12:27:03Z","timestamp":1724934423000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/191\/2\/126\/7720649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,25]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,8,5]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvae088","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,8]]},"published":{"date-parts":[[2024,7,25]]}}}